Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung Cancer

Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung Cancer

Pemetrexed is approved as a first-line treatment for advanced non-squamous non-small cell lung cancer (NSCLC) with cisplatin and as a single agent for second-line treatment or for patients who show no disease progression after four cycles of platinum-based doublet induction chemotherapy as maintenan...

Full description

Bibliographic Details
Main Authors: Kim, Kyeong-Hyun, Song, Seo-Young, Lim, Kyu-Hyoung, Han, Seon-Sook, Kim, Se-Hyun, Cho, Jun Hwi, Park, Chan Woo, Lee, Seoungkoo, Lee, Hui-Young
Format: Online
Language:English
Published: Korean Cancer Association 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629367/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629367/

Similar Items